The University of Iowa
The University of Iowa News Services Home News Releases UI in the News Subscribe to UI News Contact Us
5137 Westlawn
Iowa City IA 52242
(319) 335-9917; fax(319) 384-4638

Release: Aug. 23, 2002

People with Parkinson's disease invited to participate in medication study

The department of neurology at University of Iowa Hospitals and Clinics is beginning the study of a new medication for Parkinson's disease. This new agent is intended to slow down or stop the progression of Parkinson's disease by preventing the death of brain cells that occurs in this condition.

The study of this drug is being conducted in cooperation with the Parkinson's Study Group, a group of academic medical centers in North America devoted to the development of new, effective therapies for Parkinson's disease.

Patients who have been diagnosed with Parkinson's disease for less than five years and who are not taking any Parkinson's medications may be eligible to participate in the program.

The study is for 24 months with 12 clinical visits. Two all-expense paid trips to the Institute for Neurodegenerative Disorders in New Haven, Conn., will also be required.

Inquires can be directed to Judith Dobson at (319) 356-8958.

University of Iowa Health Care describes the partnership between the UI Roy J. and Lucille A. Carver College of Medicine and UI Hospitals and Clinics and the patient care, medical education and research programs and services they provide. Visit UI Health Care online at